RE: Ask yourself one question about hemo ...26 Nov 2025 12:02
😆 “Do you honestly believe Vlad would have stated explicitly in a prospectus he is speaking to pharma and if in the worst case he couldn’t raise $5.6m”
You cannot be serious. These are the people, the “LTHs”, you are trusting with information when such statements are made. Yikes.
“the Directors would use ALL ENDEAVOURS to sell an interest in the development of HG-CT-1, as well as its other product candidates. The Directors are REASONABLY confident that they would be able to do so”
It is not guaranteed, as you seem to suggest. Being reasonably confident is not the same as certainty.
It is unlikely to be on favourable terms overall.
It is not a positive as you assume, as any sale would likely involve giving it away at a discount if you believe in the eventual value or potential. It is not something I would be touting, as it reads more like a last resort than a preferred course of action.
The fact remains that £5.6 million in funding is required by January. It is fairly clear that selling an interest is not the preferred option, nor is it sounding as it would likely to be favourable/ secure best value, and it would be unlikely to even be possible to conclude in a month. Inevitably, any attempt could cause delays, and that is assuming a sale can even be agreed.
In the best world, non dilutive funding from somewhere, medium the fleecers rinse and repeat shareholders, worse case I suspect CLNs would be a preference over a sale but that’s just my thoughts. In all circumstances, it should not have been left this late and that’s just my thoughts.